Khalilah James
Adult Health · New York, NYNPI 1689146763
Payments from drug & device makers
Across 226 payments — averaging $41.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Abbott$1K
- Novo Nordisk$625
- Cvrx, Inc.$613
- Novartis$578
- plus $3K from 21 others
What the payments were for
- Travel & lodging$3814%
- Food & beverage$9,01396%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $2,491 |
| Boehringer Ingelheim | 23 | $1,266 |
| Abbott | 14 | $1,111 |
| Novo Nordisk | 17 | $625 |
| Cvrx, Inc. | 5 | $613 |
| Novartis | 33 | $578 |
| E.r. Squibb & Sons, L.L.C. | 15 | $470 |
| United Therapeutics Corporation | 3 | $353 |
| Scpharmaceuticals Inc. | 6 | $236 |
| Abiomed | 2 | $209 |
| Merck | 9 | $207 |
| Atricure, Inc. | 2 | $167 |
| Bridgebio Pharma, Inc. | 10 | $152 |
| Lexicon Pharmaceuticals, Inc. | 6 | $136 |
| Johnson & Johnson | 4 | $118 |
| Alnylam Pharmaceuticals Inc. | 3 | $86 |
| Amgen | 4 | $83 |
| Impulse Dynamics (USA) Inc. | 2 | $81 |
| Pfizer | 4 | $76 |
| Heartflow, Inc. | 3 | $65 |
| Daiichi Sankyo Inc. | 2 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $47 |
| Philips North America LLC | 1 | $38 |
| Bayer | 2 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$737
- JARDIANCE$606
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$552
- Barostim Neo System$496
- LOKELMA$478
- WAINUA$374
- CARDIOMEMS$341
- Ozempic$249
- CAMZYOS$150
- SYNERGY ABLATION SYSTEM$141
- FUROSCIX$118
- BRILINTA$110
How this compares
$9,394 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 88 | $100,766 |
| JardianceEmpagliflozin | 84 | $72,175 |
| EliquisApixaban | 31 | $30,582 |
| FarxigaDapagliflozin Propanediol | 23 | $21,708 |
| OzempicSemaglutide | 11 | $11,714 |
| Metoprolol Succinate | 63 | $1,264 |
| Eplerenone | 18 | $1,245 |
| Atorvastatin Calcium | 35 | $656 |
| Carvedilol | 33 | $490 |
| Rosuvastatin Calcium | 33 | $469 |
| Spironolactone | 59 | $426 |
| Torsemide | 26 | $392 |
| Digoxin | 23 | $353 |
| Amiodarone Hcl | 14 | $186 |
| Ezetimibe | 13 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $578 | $100,76688 claims |
| Boehringer IngelheimJardiance | $1,266 | $72,17584 claims |
| PfizerEliquis | $76 | $30,58231 claims |
| AstraZenecaFarxiga | $2,491 | $21,70823 claims |
| Novo NordiskOzempic | $625 | $11,71411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.